|
Note: Print this page for easy reference
|
Supportive Care:
Therapeutic Strategies for CINV Tuesday, November 29th, 2005 2 – 3 PM (ET) |
|
NOTE: The
VitalSignsTV Broadcast Program is now complete. To view
this program as an on-demand webcast, please log on
to: www.SupportiveCareCINV.com
(after Dec. 6, 2005) If you have questions regarding your educational credit, contact the sponsor at 718-920-6674.
Financial support for this activity is provided by an unrestricted
educational grant from Merck and Co., Inc. Faculty Chair Missak Haigentz, MD, Associate Director – Clinical
Trials Office, Albert Einstein College of Medicine, New York, NY Other Faculty Una Hopkins, NP, Nurse Practitioner, John Timoney, PharmD,
Clinical Pharmacy Specialist, Target Audience This activity is intended for oncologists,
pharmacists, oncology nurses and other healthcare professionals in oncology
interested in learning about chemotherapy and chemotherapy-induced nausea and
vomiting (CINV) and the treatment options of the past, present and future. Statement of Need Chemotherapy-induced nausea and
vomiting (CINV) continues to afflict cancer patients to a great extent. An
estimated 60 to 80% of patients receiving chemotherapy experience some level
of nausea and vomiting. The individual risk of developing CINV is dependent
upon both patient-related and treatment-related factors. Patient factors that
indicate a higher risk of CINV are female gender, age 50 and under, no
alcohol use, susceptibility to motion sickness and prior episodes of CINV.
Treatment-related factors associated with higher rates of CINV include
chemotherapy, combination chemotherapy, higher doses of chemotherapy and
high-dose intensity chemotherapy. Activity Goal: The goal of this activity is to present
information that will enable participants to provide better care to those
patients that they manage who present, or indicate that they are suffering
with chemotherapy-induced nausea and vomiting. Learning Objectives Upon completion of this activity, the participants should be able to: ·
Discuss quality of life issues surrounding
importance of prevention and effective management of nausea and vomiting in
patients undergoing chemotherapy. ·
Discuss treatment issues related to CINV and what current
unmet needs exist in this therapeutic area. ·
Describe consensus guidelines for the treatment of
CINV. ·
Discuss neuropharmacology
of CINV and therapeutic options available in its management. ·
Individualize the pharmacologic regimen for the
management of CINV. ACCREDITATION/DESIGNATION STATEMENT Albert Einstein College of Medicine is accredited by the Accreditation
Council for Continuing Medical Education to provide continuing medical
education for physicians. Physicians:
Albert Einstein College of Medicine designates this educational
activity for a maximum of 1 Category 1 Credit toward the AMA Physician's
Recognition Award. Each physician should claim those credits that he/she
actually spent in the educational activity. This CME activity was planned and produced in accordance with the
ACCME Essentials.
This program is approved for 1 hour credit (0.1 CEUs)
and is co-sponsored with the University of Tennessee College of Pharmacy who
is approved by the American Council for Pharmacy Education as a provider of
continuing pharmacy education. A statement of CE credit will be mailed to
participants within 4 weeks of successful completion and evaluation of the
program. ACPE Program #064-999-05-274-H01 Grievance Policy: A participant, sponsor, faculty member or other
individual wanting to file a grievance with respect to any aspect of a
program sponsored or co-sponsored by the UTCOP may contact the Associate Dean
for Continuing Education in writing. The grievance will be reviewed and a
response will be returned within 45 days of receiving the written statement.
If not satisfied, an appeal to the Dean of the Nurses: Nurses attending this program will receive
contact hours. Live Broadcast – November 29, 2005 To receive a statement of CEU credit, attendance must be acknowledged
at the registration desk upon arrival at the broadcast site, and the
participant must complete the activity attendance sheet, evaluation form and
either fax these to Steven Jay Feld at
718-798-2336, or mail them to: Steven Jay Feld CCME To receive a statement of CE credit, the participant must complete the
activity attendance sheet, evaluation form and test and fax these to Steven
Jay Feld at 718-798-2336, or mail them to: Steven Jay Feld CCME CONFLICT OF INTEREST STATEMENT The "Conflict of Interest Disclosure Policy" of Albert
Einstein College of Medicine requires that faculty participating in any CME
activity disclose to the audience any relationship(s) with a pharmaceutical or
equipment company. Any presenter whose disclosed
relationships prove to create a conflict of interest, with regard to their
contribution to the activity, will not be permitted to present. The Albert Einstein College of Medicine also requires that the faculty
participating in any CME activity disclose to the audience when discussing
any unlabeled or investigational use of any commercial product, or device,
not yet approved for use in the |
|
|
©Copyright VitalSigns
Healthcare TV |
|
